BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17238269)

  • 1. Predicting class I major histocompatibility complex (MHC) binders using multivariate statistics: comparison of discriminant analysis and multiple linear regression.
    Doytchinova IA; Flower DR
    J Chem Inf Model; 2007; 47(1):234-8. PubMed ID: 17238269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
    Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
    J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of peptide binding affinity to class I mouse major histocompatibility complexes: a comparative molecular similarity index analysis (CoMSIA) study.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    J Chem Inf Model; 2005; 45(5):1415-23. PubMed ID: 16180918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
    Bordner AJ; Abagyan R
    Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity.
    Hattotuwagama CK; Guan P; Doytchinova IA; Flower DR
    Org Biomol Chem; 2004 Nov; 2(22):3274-83. PubMed ID: 15534705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II HLA-peptide binding prediction using structural principles.
    Mohanapriya A; Lulu S; Kayathri R; Kangueane P
    Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.
    Du QS; Wei YT; Pang ZW; Chou KC; Huang RB
    Protein Eng Des Sel; 2007 Sep; 20(9):417-23. PubMed ID: 17681974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods and protocols for prediction of immunogenic epitopes.
    Tong JC; Tan TW; Ranganathan S
    Brief Bioinform; 2007 Mar; 8(2):96-108. PubMed ID: 17077136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
    Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
    Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
    Tung CW; Ho SY
    Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical properties.
    Cui J; Han LY; Lin HH; Zhang HL; Tang ZQ; Zheng CJ; Cao ZW; Chen YZ
    Mol Immunol; 2007 Feb; 44(5):866-77. PubMed ID: 16806474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPPP: MHC class I antigenic peptide processing prediction.
    Hakenberg J; Nussbaum AK; Schild H; Rammensee HG; Kuttler C; Holzhütter HG; Kloetzel PM; Kaufmann SH; Mollenkopf HJ
    Appl Bioinformatics; 2003; 2(3):155-8. PubMed ID: 15130801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design.
    Halling-Brown M; Shaban R; Frampton D; Sansom CE; Davies M; Flower D; Duffield M; Titball RW; Brusic V; Moss DS
    Mol Immunol; 2009 Aug; 46(13):2699-705. PubMed ID: 19560824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of peptide-MHC binding using profiles.
    Reche PA; Reinherz EL
    Methods Mol Biol; 2007; 409():185-200. PubMed ID: 18450001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative prediction of MHC-II binding affinity using particle swarm optimization.
    Zhang W; Liu J; Niu Y
    Artif Intell Med; 2010 Oct; 50(2):127-32. PubMed ID: 20541921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of T-cell epitopes using biosupport vector machines.
    Yang ZR; Johnson FC
    J Chem Inf Model; 2005; 45(5):1424-8. PubMed ID: 16180919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative online prediction of peptide binding to the major histocompatibility complex.
    Hattotuwagama CK; Guan P; Doytchinova IA; Zygouri C; Flower DR
    J Mol Graph Model; 2004 Jan; 22(3):195-207. PubMed ID: 14629978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EpiTOP--a proteochemometric tool for MHC class II binding prediction.
    Dimitrov I; Garnev P; Flower DR; Doytchinova I
    Bioinformatics; 2010 Aug; 26(16):2066-8. PubMed ID: 20576624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.